This inventor holds 1 USPTO granted patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Qingmin Wang: Innovator in Pharmaceutical Composition
Introduction
Qingmin Wang is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy.
Latest Patents
Qingmin Wang holds 1 patent for his work titled "Composition comprising aflibercept and a variant thereof, and related methods and uses." This patent describes a composition that includes aflibercept and a truncation variant with a reduced VEGF binding portion. The variant's content is limited to about 20% by mass percentage. Additionally, the patent outlines a pharmaceutical formulation that incorporates this composition, along with methods for detecting the variant and its applications in quality inspection or control of aflibercept-containing products.
Career Highlights
Qingmin Wang is associated with Qilu Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His work focuses on advancing drug formulations and improving the quality of pharmaceutical products.
Collaborations
Qingmin Wang collaborates with esteemed colleagues, including Yue Yu and Guijiang Wang, to further enhance the research and development efforts within his field.
Conclusion
Qingmin Wang's innovative contributions to pharmaceutical compositions demonstrate his commitment to improving healthcare solutions. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile